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Abstract
Background: The TNM classification (sixth edition) requires at least 15 lymph nodes to be
examined to allow an accurate staging. However, in our environment, only 20% of patients have
the recommended minimum of 15 nodes removed.
Purpose: To evaluate clinicopathological predictors of recurrence in patients with gastric cancer
undergoing radical resection with an inadequate number of lymph nodes examined.
Methods: 101 patients were included in this retrospective cohort. We evaluated age, gender,
tumoral location, Borrmann type, Lauren histotype, type of gastrectomy, grade, invasion depth of
tumor, lymph node involvement, ratio between metastatic and total number of excised lymph
nodes keeping 20% as the cutoff value (LNR) and adjuvant treatment. The association between
these variables and recurrence was investigated by using univariate methods and multivariate
logistic regression analysis.
Results: Median (range) age was 63 years (44-85). 63% males, 37% females. Median follow-up time
for the whole patients population was 36 months (10-104). Median number of lymph nodes
retrieved was 6 (0-14). Recurrence: 50 of 101 cases (49,6%); 41 hematogeneus dissemination, 9
locoregional recurrences. The following factors were found to be correlated with the recurrence
risk: tumoral location, invasion depth of tumor, lymph node involvement and LNR. A multivariate
analysis revealed that depth of invasion [odds ratio (OR) 2.80, 95% confidence interval (CI) 1.03-
7.58, P = 0.04] and LNR (OR 2.34, 95% CI 1.05-5.21, P = 0.03) were independent risk factors for
recurrences of gastric cancer. Median time to recurrence: 16 months (2-50). 82% of recurrences
occurred within the first two years after surgical treatment. The estimated cumulative risk of
recurrence at five years: 61% in the whole patients population, with serosal invasion and LNR >
and < 20% was 82% and 44%, without serosal invasion 73% and 39% respectively.
Conclusion: Invasion depth of tumor and LNR were independent predictors of recurrence in
gastric cancer after potentially curative resection with an inadequate number of lymph nodes
examined.
Correspondence
Metastasis of the lymph node (MLN) is one of the most
important prognostic factors in gastric cancer [1].
Although Aurello et al. [2] have indicated that the number
of nodes necessary to conclude N0 may vary according to
the depth of tumor invasion (T), the TNM classification
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requires the retrieval and analysis of at least 15 lymph
nodes for accurate staging. However, in most cases, the
number of nodes dissected is smaller and only 20 to 30%
of the patients have the recommended minimum dissec-
tion of 15 nodes.
Although previous studies have indicated that the lymph-
node ratio (LNR), which is defined as the ratio of the
number of MLN to the total number of nodes found dur-
ing pathological examination, is a powerful independent
prognostic factor [3,4] with significant superiority in min-
imizing "stage migration" for patients with more than 15
nodes evaluated, it remains controversial whether this
result is applicable to patients with inadequate staging [5].
Many published studies report different cut offs for LNR,
but the consensus value seems to be 20% [6].
We carried out an institutional retrospective study to
investigate the relationship between classical clinico-
pathological features and LNR (using 20% as the cut off
value) and the prognosis in patients with gastric cancer
who underwent an apparently radical resection but who
had an insufficient number of lymph nodes retrieved
(and, therefore, were inadequately staged).
One hundred and one patients were included in the study
from 2003 to 2006. The median age was 63 years (range,
44-85 years) and 63% of patients were male. The median
follow-up time was 36 months (range, 10-104 months)
and the median number of lymph nodes analyzed was six
(range, 0-14 nodes). Recurrence was detected in 50 out of
101 cases (49,6%), 41 patients presented hematogenous
dissemination as the main location (20 of them presented
also locoregional recurrence with lymph nodes involved
in 13 patients), and nine patients had only locoregional
recurrence (see Table 1). The high recurrence rate
observed in this population could be explained by the
selection process, which was based on limited lymph
node dissection and could lead to an increase in the
likelihood of understaging. Many studies have indicated
that the number of metastatic nodes in patients with rad-
ically resected gastric cancer increases with the number of
lymph nodes removed [7].
The following factors were correlated with the recurrence
risk: tumoral location, invasion depth of the tumor,
lymph-node involvement (pN), and LNR.
A multivariate analysis of our data revealed that depth of
invasion [odds ratio (OR), 2.80; 95% confidence interval
(CI), 1.03-7.58; P = 0.04] and LNR (OR, 2.34; 95% CI,
1.05-5.21; P = 0.03) were independent risk factors for the
recurrence of gastric cancer.
The median time to recurrence was 16 months (range, 2-
50 months). Eighty-two percent of recurrences occurred
within the first two years after surgical treatment. The esti-
mated cumulative risk of recurrence at five years was 61%
in the whole population; in the case of serosal invasion
and LNR > and ≤ 20%, this risk was 82% and 44%, respec-
tively; without serosal invasion, the risk was 73% and
39%, respectively with LNR > and ≤ 20%.
Although we did not apply any specific method to select
the LNR cut off, we nevertheless obtained an interesting
and significant result considering 20% as the cut off most
frequently used. It is clear that the fewer the nodes exam-
ined, the lower was the accuracy of the prognostic system.
Our study revealed that depth of tumor invasion and LNR
with a 20% cutoff value were independent and significant
predictors of recurrence in gastric cancer after potentially
curative resection with examination of an inadequate
number of lymph nodes.
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